Pharming Group Stock Target Price and Analyst Consensus
| PHAR Stock | USD 8.80 0.04 0.46% |
The current analyst and expert consensus on Pharming Group is Strong Buy, with 2 strong buy opinions. The current projected Pharming Group target price consensus is 27.00 with 3 analyst opinions. Check out Macroaxis Advice on Pharming Group to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. The most common way Pharming Group NV analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Pharming Group executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Pharming Group. We encourage you to use your own analysis of Pharming Group NV to validate this buy or sell advice. Pharming Group buy-or-sell recommendation module provides average expert sentiment on the projected Pharming Group NV target price to derive its highest and lowest estimates based on projected price volatility of 3.7443.
Lowest Forecast 24.57 | Highest Forecast 29.97 | Target Price 27 |
Pharming |
It's important to approach Pharming Group's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Pharming Group price targets
Pharming Group's stock target price is an estimate of its future price, usually made by analysts. Using Pharming Group's target price to determine if it is a suitable investment can be done through the following steps:- Look at Pharming Group's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Pharming Group's stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Pharming Group Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Pharming Group is a key component of Pharming Group valuation and have some predictive power on the future returns of a Pharming Group.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Macroaxis Index Invested over 90 shares | |
 | Utilities Invested over 90 shares | |
 | Apparel Invested over 90 shares | |
 | Impulse Invested over 100 shares | |
 | Banking Invested over 30 shares | |
 | ESG Investing Invested few shares | |
 | Driverless Cars Invested over 60 shares | |
 | Manufacturing Invested over 30 shares | |
 | FinTech Invested over 30 shares | |
 | Business Services Invested few shares | |
 | Insurance Invested over 200 shares | |
Additional Tools for Pharming Stock Analysis
When running Pharming Group's price analysis, check to measure Pharming Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharming Group is operating at the current time. Most of Pharming Group's value examination focuses on studying past and present price action to predict the probability of Pharming Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharming Group's price. Additionally, you may evaluate how the addition of Pharming Group to your portfolios can decrease your overall portfolio volatility.